These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26385769)

  • 21. A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing.
    Moriwaki K; Bertin J; Gough PJ; Chan FK
    J Immunol; 2015 Feb; 194(4):1938-44. PubMed ID: 25567679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
    Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
    Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RIPK3 in cell death and inflammation: the good, the bad, and the ugly.
    Orozco S; Oberst A
    Immunol Rev; 2017 May; 277(1):102-112. PubMed ID: 28462521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of RIPK1 and RIPK3 in Cardiovascular Disease.
    DeRoo E; Zhou T; Liu B
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
    Peng R; Wang CK; Wang-Kan X; Idorn M; Kjaer M; Zhou FY; Fiil BK; Timmermann F; Orozco SL; McCarthy J; Leung CS; Lu X; Bagola K; Rehwinkel J; Oberst A; Maelfait J; Paludan SR; Gyrd-Hansen M
    EMBO Rep; 2022 Dec; 23(12):e55839. PubMed ID: 36268590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs.
    Martens S; Hofmans S; Declercq W; Augustyns K; Vandenabeele P
    Trends Pharmacol Sci; 2020 Mar; 41(3):209-224. PubMed ID: 32035657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death.
    Thapa RJ; Ingram JP; Ragan KB; Nogusa S; Boyd DF; Benitez AA; Sridharan H; Kosoff R; Shubina M; Landsteiner VJ; Andrake M; Vogel P; Sigal LJ; tenOever BR; Thomas PG; Upton JW; Balachandran S
    Cell Host Microbe; 2016 Nov; 20(5):674-681. PubMed ID: 27746097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1.
    Justus SJ; Ting AT
    Immunol Rev; 2015 Jul; 266(1):145-60. PubMed ID: 26085213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed necrosis in the cross talk of cell death and inflammation.
    Chan FK; Luz NF; Moriwaki K
    Annu Rev Immunol; 2015; 33():79-106. PubMed ID: 25493335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of necroptosis in pulmonary diseases.
    Mizumura K; Maruoka S; Gon Y; Choi AM; Hashimoto S
    Respir Investig; 2016 Nov; 54(6):407-412. PubMed ID: 27886851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2.
    Wagner RN; Reed JC; Chanda SK
    Retrovirology; 2015 Aug; 12():74. PubMed ID: 26297639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival.
    Rodrigue-Gervais IG; Labbé K; Dagenais M; Dupaul-Chicoine J; Champagne C; Morizot A; Skeldon A; Brincks EL; Vidal SM; Griffith TS; Saleh M
    Cell Host Microbe; 2014 Jan; 15(1):23-35. PubMed ID: 24439895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple roles of caspase-8 in cell death, inflammation, and innate immunity.
    Orning P; Lien E
    J Leukoc Biol; 2021 Jan; 109(1):121-141. PubMed ID: 32531842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.
    Rucker AJ; Chan FK
    Trends Biochem Sci; 2022 Apr; 47(4):342-351. PubMed ID: 34998669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting RIPK1,2,3 to combat inflammation.
    Bullock AN; Degterev A
    Oncotarget; 2015 Oct; 6(33):34057-8. PubMed ID: 26472031
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.
    Najjar M; Suebsuwong C; Ray SS; Thapa RJ; Maki JL; Nogusa S; Shah S; Saleh D; Gough PJ; Bertin J; Yuan J; Balachandran S; Cuny GD; Degterev A
    Cell Rep; 2015 Mar; 10(11):1850-60. PubMed ID: 25801024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIPK3 and RIPK1 gene expression in pterygium: unveiling molecular insights into pathogenesis.
    Divandari M; Javadifar A; Moghadam AB; Janatabadi AA
    Mol Biol Rep; 2024 Apr; 51(1):524. PubMed ID: 38630344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3.
    Seo J; Lee EW; Sung H; Seong D; Dondelinger Y; Shin J; Jeong M; Lee HK; Kim JH; Han SY; Lee C; Seong JK; Vandenabeele P; Song J
    Nat Cell Biol; 2016 Mar; 18(3):291-302. PubMed ID: 26900751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications.
    Ke D; Zhang Z; Liu J; Chen P; Dai Y; Sun X; Chu Y; Li L
    Front Immunol; 2023; 14():1274654. PubMed ID: 37954576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.